Lung cancer remains a leading cause of death globally, but recent advancements in diagnostic techniques and targeted therapies offer new hope for patients. A significant focus is on the genetic profiling of non-small cell lung cancer and the role of immunotherapy in improving survival rates, even in early stages. The congress titled ‘Managing Patients with Lung Cancer in Clinical Practice’ will be held on November 8-9 at the KEDAA Aristotle University of Thessaloniki, aimed at fostering collaboration among medical specialties and enhancing knowledge in the field.